GlaxoSmithKline Pharmaceuticals Ltd.

BSE: 500660 | NSE: GLAXO |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE159A01016 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

GlaxoSmithKlin GlaxoSmithKline Pharmaceuticals Ltd. | BSE 2395.05 31.45 (1.33%) | NSE 2401.60 35.00 (1.48%) | Trade | Add

BSE Live

Jan 30, 16:01

2395.05 31.45 (1.33%)

Volume

AVERAGE VOLUME

5-Day

2,887

10-Day

3,025

30-Day

2,918

1,805

Prev. Close

2363.60
Open Price

2375.40

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jan 30, 15:53

2401.60 35.00 (1.48%)

Volume

AVERAGE VOLUME

5-Day

74,948

10-Day

71,397

30-Day

80,639

109,753

Prev. Close

2366.60
Open Price

2359.90

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2401.60 (195)

Financials

Print/Copy to Excel : Go

Balance Sheet of GlaxoSmithKline Pharmaceuticals (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	169.41	169.41	84.70	84.70	84.70
Total Share Capital	169.41	169.41	84.70	84.70	84.70
Reserves and Surplus	1,670.63	1,973.01	1,995.25	1,943.51	2,119.94
Total Reserves and Surplus	1,670.63	1,973.01	1,995.25	1,943.51	2,119.94
Total Shareholders Funds	1,840.04	2,142.42	2,079.95	2,028.21	2,204.64
NON-CURRENT LIABILITIES
Long Term Borrowings	0.02	0.18	0.58	0.99	1.60
Deferred Tax Liabilities [Net]	0.00	0.00	0.00	0.00	0.00
Other Long Term Liabilities	28.90	2.19	2.24	3.49	5.66
Long Term Provisions	260.49	313.52	286.20	271.00	283.90
Total Non-Current Liabilities	289.41	315.90	289.02	275.48	291.16
CURRENT LIABILITIES
Short Term Borrowings	0.00	0.00	0.00	0.00	0.00
Trade Payables	354.19	402.96	502.53	275.92	323.09
Other Current Liabilities	367.22	956.03	996.42	393.29	206.66
Short Term Provisions	280.67	91.89	97.10	48.25	45.11
Total Current Liabilities	1,002.07	1,450.88	1,596.04	717.46	574.86
Total Capital And Liabilities	3,131.52	3,909.19	3,965.02	3,021.15	3,070.67
ASSETS
NON-CURRENT ASSETS
Tangible Assets	706.97	364.45	250.13	252.71	204.04
Intangible Assets	49.63	65.54	72.68	0.00	0.00
Capital Work-In-Progress	120.12	1,002.64	922.90	573.22	267.67
Other Assets	1.47	1.62	1.76	0.00	5.96
Fixed Assets	878.18	1,434.25	1,247.47	863.50	477.67
Non-Current Investments	24.49	24.55	47.67	47.67	47.67
Deferred Tax Assets [Net]	108.85	60.48	103.05	91.31	100.81
Long Term Loans And Advances	8.22	11.43	14.58	13.28	13.85
Other Non-Current Assets	355.00	387.29	389.20	355.55	282.87
Total Non-Current Assets	1,374.74	1,918.01	1,801.96	1,371.31	922.87
CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.00	0.00
Inventories	483.03	486.49	500.18	425.48	521.66
Trade Receivables	99.80	120.49	146.96	170.80	126.57
Cash And Cash Equivalents	1,066.41	1,155.33	1,279.69	882.23	1,377.68
Short Term Loans And Advances	0.00	0.00	0.00	0.00	55.13
OtherCurrentAssets	107.54	228.87	236.22	171.33	66.77
Total Current Assets	1,756.78	1,991.18	2,158.11	1,648.22	2,142.05
Total Assets	3,131.52	3,909.19	3,965.02	3,021.15	3,070.67
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	483.04	573.52	704.92	982.95	1,315.04
CIF VALUE OF IMPORTS
Raw Materials	0.00	0.00	0.00	0.00	76.91
Stores, Spares And Loose Tools	0.00	0.00	0.00	0.00	342.97
Trade/Other Goods	0.00	0.00	0.00	0.00	342.97
Capital Goods	0.00	0.00	0.00	0.00	0.27
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency	874.97	709.05	742.89	719.28	11.24
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS
Dividend Remittance In Foreign Currency	--	--	--	--	397.05
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods	--	--	--	--	0.44
Other Earnings	27.57	53.38	56.37	52.78	51.47
BONUS DETAILS
Bonus Equity Share Capital	125.39	125.39	40.69	40.69	40.69
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	--	--	--	--	--
Non-Current Investments Unquoted Book Value	24.49	24.55	47.67	47.67	0.06
CURRENT INVESTMENTS
Current Investments Quoted Market Value	--	--	--	--	--
Current Investments Unquoted Book Value	--	--	--	--	--